John Moroney to Drug Resistance, Neoplasm
This is a "connection" page, showing publications John Moroney has written about Drug Resistance, Neoplasm.
Connection Strength
0.046
-
Mirvetuximab Soravtansine in FRa-Positive, Platinum-Resistant Ovarian Cancer. N Engl J Med. 2023 Dec 07; 389(23):2162-2174.
Score: 0.046